Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretin on Energy Homeostasis
NCT04613700Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Mar 2020
- Primary completion
- Sep 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity comparing Secretin with Placebo (2 arms). Primary endpoints: Food intake on ad libitum meal at 300 minutes and Duration of ad libitum meal at 300 minutes. Started Mar 2020; status: completed.
02
Drugs
secretin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04613700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04613700.